Cargando…

Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling

In the absence of an established gold standard, an understanding of the testing cycle from individual exposure to test outcome report is required to guide the correct interpretation of severe acute respiratory syndrome-coronavirus-2 reverse transcriptase real-time polymerase chain reaction (RT-PCR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yue, Foley, David, Ramsay, Jessica, Woodberry, Owen, Mascaro, Steven, Nicholson, Ann E., Snelling, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314199/
https://www.ncbi.nlm.nih.gov/pubmed/34165071
http://dx.doi.org/10.1017/S0950268821001357
_version_ 1783729495616782336
author Wu, Yue
Foley, David
Ramsay, Jessica
Woodberry, Owen
Mascaro, Steven
Nicholson, Ann E.
Snelling, Tom
author_facet Wu, Yue
Foley, David
Ramsay, Jessica
Woodberry, Owen
Mascaro, Steven
Nicholson, Ann E.
Snelling, Tom
author_sort Wu, Yue
collection PubMed
description In the absence of an established gold standard, an understanding of the testing cycle from individual exposure to test outcome report is required to guide the correct interpretation of severe acute respiratory syndrome-coronavirus-2 reverse transcriptase real-time polymerase chain reaction (RT-PCR) results and optimise the testing processes. Bayesian network models have been used within healthcare to bring clarity to complex problems. We use this modelling approach to construct a comprehensive framework for understanding the real-world predictive value of individual RT-PCR results. We elicited knowledge from domain experts to describe the test process through a facilitated group workshop. A preliminary model was derived based on the elicited knowledge, then subsequently refined, parameterised and validated with a second workshop and one-on-one discussions. Causal relationships elicited describe the interactions of pre-testing, specimen collection and laboratory procedures and RT-PCR platform factors, and their impact on the presence and quantity of virus and thus the test result and its interpretation. By setting the input variables as ‘evidence’ for a given subject and preliminary parameterisation, four scenarios were simulated to demonstrate potential uses of the model. The core value of this model is a deep understanding of the total testing cycle, bridging the gap between a person's true infection status and their test outcome. This model can be adapted to different settings, testing modalities and pathogens, adding much needed nuance to the interpretations of results.
format Online
Article
Text
id pubmed-8314199
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-83141992021-08-02 Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling Wu, Yue Foley, David Ramsay, Jessica Woodberry, Owen Mascaro, Steven Nicholson, Ann E. Snelling, Tom Epidemiol Infect Short Paper In the absence of an established gold standard, an understanding of the testing cycle from individual exposure to test outcome report is required to guide the correct interpretation of severe acute respiratory syndrome-coronavirus-2 reverse transcriptase real-time polymerase chain reaction (RT-PCR) results and optimise the testing processes. Bayesian network models have been used within healthcare to bring clarity to complex problems. We use this modelling approach to construct a comprehensive framework for understanding the real-world predictive value of individual RT-PCR results. We elicited knowledge from domain experts to describe the test process through a facilitated group workshop. A preliminary model was derived based on the elicited knowledge, then subsequently refined, parameterised and validated with a second workshop and one-on-one discussions. Causal relationships elicited describe the interactions of pre-testing, specimen collection and laboratory procedures and RT-PCR platform factors, and their impact on the presence and quantity of virus and thus the test result and its interpretation. By setting the input variables as ‘evidence’ for a given subject and preliminary parameterisation, four scenarios were simulated to demonstrate potential uses of the model. The core value of this model is a deep understanding of the total testing cycle, bridging the gap between a person's true infection status and their test outcome. This model can be adapted to different settings, testing modalities and pathogens, adding much needed nuance to the interpretations of results. Cambridge University Press 2021-06-23 /pmc/articles/PMC8314199/ /pubmed/34165071 http://dx.doi.org/10.1017/S0950268821001357 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Paper
Wu, Yue
Foley, David
Ramsay, Jessica
Woodberry, Owen
Mascaro, Steven
Nicholson, Ann E.
Snelling, Tom
Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling
title Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling
title_full Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling
title_fullStr Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling
title_full_unstemmed Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling
title_short Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling
title_sort bridging the gaps in test interpretation of sars-cov-2 through bayesian network modelling
topic Short Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314199/
https://www.ncbi.nlm.nih.gov/pubmed/34165071
http://dx.doi.org/10.1017/S0950268821001357
work_keys_str_mv AT wuyue bridgingthegapsintestinterpretationofsarscov2throughbayesiannetworkmodelling
AT foleydavid bridgingthegapsintestinterpretationofsarscov2throughbayesiannetworkmodelling
AT ramsayjessica bridgingthegapsintestinterpretationofsarscov2throughbayesiannetworkmodelling
AT woodberryowen bridgingthegapsintestinterpretationofsarscov2throughbayesiannetworkmodelling
AT mascarosteven bridgingthegapsintestinterpretationofsarscov2throughbayesiannetworkmodelling
AT nicholsonanne bridgingthegapsintestinterpretationofsarscov2throughbayesiannetworkmodelling
AT snellingtom bridgingthegapsintestinterpretationofsarscov2throughbayesiannetworkmodelling